Medicine & Life Sciences
Transplant Recipients
100%
Cytomegalovirus
87%
HIV
85%
Infections
82%
Coronavirus
67%
Transplants
59%
Adenoviridae
49%
Cytomegalovirus Infections
49%
Liver Transplantation
45%
T-Lymphocytes
42%
Therapeutics
41%
HIV-1
40%
Antiviral Agents
38%
Vaccines
37%
SARS Virus
36%
HIV Infections
36%
Virus Diseases
35%
Viruses
34%
Organ Transplantation
32%
Endocarditis
29%
Equipment and Supplies
28%
Apoptosis
26%
Hepacivirus
26%
Vaccination
23%
Mortality
23%
Human Herpesvirus 6
23%
Opportunistic Infections
23%
Transplantation
22%
Serogroup
22%
Community-Based Participatory Research
21%
Tuberculosis
20%
Severe Acute Respiratory Syndrome
20%
Pharmaceutical Preparations
20%
Pandemics
19%
Bacteremia
17%
Kidney
17%
Retroviridae Infections
17%
Allografts
17%
Immunization
17%
Ganciclovir
16%
Genes
16%
Refugees
16%
Tissue Donors
16%
Protease Inhibitors
15%
Human Influenza
15%
Immunocompromised Host
15%
Joints
15%
Proteins
15%
Monoclonal Antibodies
14%
Propionic Acidemia
14%
Cell Death
14%
Genetic Therapy
14%
Chronic Hepatitis C
14%
Epidemiology
14%
Population
13%
Mycoses
13%
Hospitalization
13%
Viremia
13%
DNA
12%
Liver
12%
Confidence Intervals
12%
Hematopoietic Stem Cells
12%
Incidence
12%
Communicable Diseases
12%
Lung
12%
Valganciclovir
11%
HIV Protease Inhibitors
11%
Ritonavir
11%
Safety
11%
Cohort Studies
11%
Viral Load
11%
In Vitro Techniques
10%
Adenovirus Vaccines
10%
Anti-Bacterial Agents
10%
Fever
10%
Human Adenoviruses
10%
Cryptococcosis
10%
Polymerase Chain Reaction
10%
Caspase 8
10%
Hematopoietic Stem Cell Transplantation
10%
Acquired Immunodeficiency Syndrome
10%
Herpesviridae Infections
9%
AIC246
9%
Reverse Transcriptase Inhibitors
9%
Morbidity
9%
Heart
9%
Heme Oxygenase-1
9%
Randomized Controlled Trials
9%
Health
9%
Peptides
9%
lens epithelium-derived growth factor
9%
Ribavirin
9%
Nelfinavir
9%
Human Herpesvirus 7
9%
Highly Active Antiretroviral Therapy
9%
Anti-Retroviral Agents
8%
Staphylococcus aureus
8%
Feline Immunodeficiency Virus
8%
Antigens
8%
Kidney Transplantation
8%